Physiological Finding in Management of COVID 19 Patients | NCT07504341

Studies
Physiological Finding in Management of COVID 19 Patients

NCT07504341

Sponsor

St. Martin De Porress Hospital

Status

Recruiting

Last Update Posted

Mar 31, 2026Actual

Enrollment

15,000Estimated

Phase

Not provided

Conditions

COVID-19 (Coronavirus Disease 2019)

Interventions

physiological parameters

Countries

Taiwan

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

ID	Type	Description	Link
26B-005	Other Identifier	St. Martin De Porres Hospital

Status Module

Record Verification Date

Mar 2026

Overall Recruitment Status or Expanded Access Status

Recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Apr 2026Estimated

Primary Completion Date

Mar 11, 2027Estimated

Completion Date

Mar 31, 2027Estimated

First Submitted Date

Mar 16, 2026

First Submission Date that Met QC Criteria

Mar 25, 2026

First Posted Date

Mar 31, 2026Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Mar 25, 2026

Last Update Posted Date

Mar 31, 2026Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Chia-hsi Chen, Physician Emergency Medicine and Critical Medicine, St. Martin De Porress HospitalPrincipal Investigator

Lead Sponsor

St. Martin De Porress HospitalOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

This study utilizes physiological indicators of COVID-19 patients as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. This study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Detailed Description

This study utilizes physiological indicators of COVID-19 patients, such as blood pressure, heart rate, respiratory rate, and level of consciousness, to develop Shock Index (SI), Mordified Shock Index (MSI), Age Shock Index (Age SI), Age Mordified Shock Index (Age MSI), and Respiratory Adjusted Shock Index (RASI), as well as other physiological indicators, as tools for assessing, tracking, worsening, and improving the clinical symptoms of COVID-19 patients. For patients with mild to severe illness, and in response to the shortage of manpower during a large influx of emergency patients, this study employs simple and easy-to-use assessment methods, which can be further aided by artificial intelligence technology to facilitate early response and medication.

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

15,000Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
COVID-19 patient		The COVID-19 patients were devided into admission ,OPD groups	Other: physiological parameters

Interventions

Name	Type	Description	Arm Group Labels	Other Names
physiological parameters	Other	systolic blood pressure, diastolic blood pressure , heart rate, respiratory rate , GCS	COVID-19 patient

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Shock index(SI) in the management of COVID -19	SI= heart rate / systolic blood pressre	2022 May to 2027 March
Mordified shock index(MSI) in the management of COVID -19	MSI=heart rate / mean arterial pressure	2022 May to 2027 March
Age shock index(Age SI) in the management of COVID -19	Age shock index =Age x (heart rate / systolic blood pression)	2022 May to 2027 March
Respiratory adjusted shock index (RASI) in the management of COVID-19	Respiratory adjusted shock index =(heart rate/systolic blood pression) x (repiratory rate/10)	2022 may to 2027 March

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Reviewing the patient's medical history, the primary focus was on hospital records and existing physiological parameters such as blood pressure, heart rate, respiratory rate, and level of consciousness. The patient received treatment at the hospital between May 2022 and March 2027

Exclusion Criteria:

Excluding patients with incomplete clinical data or missing information in their medical records.

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

Not provided

Maximum Age

Not provided

Standard Ages

ChildAdultOlder Adult

Study Population

The COVID-19 patient received treatment at the hospital between May 2022 and March 2027 from emergency room, OPD

Sampling Method

Non-Probability Sample

Contacts/Locations Module

Central Contacts

Name	Role	Phone	Extension	Email
Chia-Hsi Chen, Physician	Contact	886-5-2756000	3708	urologist3509@gmail.com
Chia-Hsi Chen	Contact	886-5-2756000	3708	urologist3509@gmail.com

Overall Officials

Name	Affiliation	Role
Chia-Hsi Chen, Physician	St. Martin De Porress Hospital	Principal Investigator

Locations

Facility	Status	City	State	ZIP	Country	Contacts
St. Martin De Porres Hospital	Recruiting	Chiayi City		60069	Taiwan
St. Martin De Porres Hospital

IPD Sharing Statement Module

Plan to Share IPD

Description

Under the privacy of patients the data of medical record can't be shared with others researchers.

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D000086382	COVID-19

Ancestor Terms

ID	Term
D011024	Pneumonia, Viral
D011014	Pneumonia
D012141	Respiratory Tract Infections
D007239	Infections

Browse Leaves

Not provided

Browse Branches

Not provided